ACP5

There are 147 papers on ACP5 in aging research: 4 trials and 12 observational studies in people, 114 in animals, 12 in cells, 4 reviews.

Gene

147 papers study it2 findings

HGNCNCBI GeneTaxon

6 new papers in 30 daysSee all 147 papers on ACP5

At a glance

The findings reach people, from one lab or study. 2 independent labs in 2 countries.

“corroborated 4 (ACP5, LEFTY2, LILRA5 and PSME2) as showing concordant differential abundance in people with DM; all were associated with a range of incident ASCVD events.”
Analysis of the diabetic arterial transcriptome to define novel biomarkers of macrovascular diseaseDiabetes & vascular disease research2026doi:10.1177/14791641261474099

None of its findings points the other way.

Cells and humans: a single group. Worms or flies and mice: nothing yet.
  • 2 independent labs in 2 countries
  • Funders: British Heart Foundation and 4 more
  • Human trial4
  • Humans12
  • Animals114
  • Cells12
  • In silico1

Effects

1

Cell migration

upin human cells1

1 study
  1. ACP5 increases cell migration in two TNBC cell lines.

    Cellsin two TNBC cell linesbreast cancer cell line

Associations

1

Atherosclerotic cardiovascular disease

upin humans1

1 study
  1. ACP5 is associated with atherosclerotic cardiovascular disease in humans (plasma proteomics in UK Biobank).

    Humansplasma proteomics in UK Biobankplasma

    Diabetes linked to distinct gene activity in human arteries

    Diabetes & vascular disease research

More on Atherosclerotic cardiovascular disease

Latest

Dec 2025: 2Jan 2026: 7Feb 2026: 9Mar 2026: 2Apr 2026: 1May 2026: 2Jun 2026: 2Jul 2026: 2Aug 2026: 7Sep 2026: 2Oct 2026: 6Nov 2026: 042 papers in 12 months

See all 147 papers on ACP5